A comprehensive view of astrazeneca ab. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

ANGLE partners with AstraZeneca to enhance cancer drug development using DNA damage response assay; companies to adapt ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumor cells
Published: April 24, 2024 by Proactive Investors
US Patent Issued to AstraZeneca on April 23 for "Inhaler" (British, Swedish Inventors)
Published: April 24, 2024 by U.S. Fed News
AstraZeneca AB Champions Sustainability and Respiratory Health Initiatives, Highlighting Decarbonization Goals and Public Health Collaboration
Published: April 23, 2024 by Industry Intelligence Inc.
AstraZeneca AB Leads Industry in Environmental Sustainability and Public Health Initiatives, Targeting Carbon Neutrality by 2025 and Carbon Negativity by 2030
Published: April 22, 2024 by Industry Intelligence Inc.
AstraZeneca Files United States Patent Application for Amino-Triazolopyridine Compounds and Their Use in Treating Cancer
Published: April 22, 2024 by Pharmaceutical Patent News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count